Conclusion As the multi-hit hypothesis holds, combining the therapeutic approaches of GLP-1 agonists with resmetirom seems like a promising strategy by targeting the multifaceted pathophysiology of MASH, which may lead to improved patient outcomes
External resources IRS Publication 502: Medical and Dental Expenses (HSA/FSA guidance) Consumer Financial Protection Bureau: Buy Now, Pay Later guide In case I do not see you, good afternoon, good evening, and good night
Zhang Y., Han P., Wu N., He B., Lu Y., Li S., Liu Y., Zhao S., Liu L., Li Y
Berberine can help some people and may support metabolic markers, but its average weight-loss effects are usually smaller and more variable
[ CrossRef ] [ Google scholar ] [ PubMed ] Milanovic M, Fan DNY, Belenki D, Dbritz JHM, Zhao Z, Yu Y, et al
Additionally, upregulated Ras-RAF-MEK pathway expression may enhance cancer cell sensitivity to ferroptosis by modulating VDAC2/3 function and increasing ROS generation (40)